Company intelligence / Profile preview

Vantis Vascular

San Jose, California, United States

Ownership: Private
Development stage: Other

Overview

Vantis Vascular's CrossFAST Integrated Microcatheter Advanced Delivery System demonstrated 100% procedural success and no device-related complications in first commercial cases, showing superior performance in complex high-risk coronary interventions; CrossSHOCK Intravascular Lithotripsy System is in development.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Vantis Vascular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vantis Vascular.

Explore the full profile